Dr. Younghoon Kwon, MD

Dr. Kwon practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Kwon's NPI, 1639377591, was assigned on July 3, 2007. Dr. Kwon holds Washington license MD61009591.

Dr. Kwon's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Kwon's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. Dr. Kwon is also affiliated with Swedish Cherry Hill Campus. The medical group on file is UW Physicians. Dmand AI also links Dr. Kwon to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kwon practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kwon's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kwon is licensed in Washington.

CMS data shows 921 Medicare services from Dr. Kwon across 6 procedure codes in 2024, for 524 Medicare patients. Medicare paid $20,913 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 524 Medicare patients who saw Dr. Kwon in 2024. The largest group is 65 to 74, with 184 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kwon's median patient age at 63, with 41% women.

In 2021, Dr. Kwon wrote 56 Medicare Part D claims. Every claim was for a generic drug. They cover 4 drugs, with $605 in total drug cost. In 2020, CMS named 99 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kwon for performance year 2024, reported through an alternative payment model (APM). Dr. Kwon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 62 general payments to Dr. Kwon from 4 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 85% of the total. Jazz Pharmaceuticals Inc. paid the most, $65,814.